These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Treatment
165 results:

  • 1. Earlier intrathecal dexamethasone effectively alleviate immune effector cell-associated neurotoxicity syndrome.
    Ji Q; Dong Y; Zhang Y; Wu X; Bai Z; Huang S; Dong X; Wang Y; Pan J; Lu J; Hu S; Wu S
    Int Immunopharmacol; 2024 Dec; 142(Pt B):113214. PubMed ID: 39321707
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The roles of phosphorylation of signaling proteins in the prognosis of acute myeloid leukemia.
    Márton A; Veres KB; Erdődi F; Udvardy M; Illés Á; Rejtő L
    Pathol Oncol Res; 2024; 30():1611747. PubMed ID: 39035053
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Regulation of Cell Cycle Progression through RB Phosphorylation by Nilotinib and AT-9283 in Human Melanoma A375P Cells.
    Pham TM; Ahmed M; Lai TH; Bahar ME; Hwang JS; Maulidi RF; Ngo QN; Kim DR
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474202
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
    Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
    Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Massive parallel sequencing unveils homologous recombination deficiency in follicular dendritic cell sarcoma.
    Lorenzi L; Haferlach T; Mori L; Simbeni M; Walter W; Balzarini P; Meggendorfer M; Döring C; Lonardi S; Bugatti M; Agostinelli C; Mehta J; Borges A; Agaimy A; Simonitsch-Klupp I; Cabeçadas J; Campo E; Pileri SA; Facchetti F; Leo Hansmann M; Hartmann S
    Haematologica; 2024 Jun; 109(6):1815-1824. PubMed ID: 37994105
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Dasatinib in combination with BMS-754807 induce synergistic cytotoxicity in lung cancer cells through inhibiting lung cancer cell growth, and inducing autophagy as well as cell cycle arrest at the G1 phase.
    Zhang C; Zhao X; Wang Z; Gong T; Zhao H; Zhang D; Niu Y; Li X; Zhao X; Li G; Dong X; Zhang L; Liu C; Xu J; Yu B
    Invest New Drugs; 2023 Jun; 41(3):438-452. PubMed ID: 37097369
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A phase I study of the combination of palbociclib and dexamethasone for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia.
    Wilde L; Porazzi P; Trotta R; De Dominici M; Palmisiano N; Keiffer G; Rancani K; Yingling K; Calabretta B; Kasner M
    Leuk Res; 2023 Jun; 129():107075. PubMed ID: 37079999
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cytotoxic Effects of Darinaparsin, a Novel Organic Arsenical, against Human leukemia Cells.
    Yuan B; Kikuchi H; Li J; Kawabata A; Yao K; Takagi N; Okazaki M
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768603
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Targeted treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic leukemia.
    Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
    Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Predictive role of NKCD56bright cells in monitoring the progression of chronic lymphocytic leukemia during treatment.
    Blachnio K; Grygalewicz B; Woroniecka R; Rygier J; Pienkowska-Grela B; Rymkiewicz G; Kawiak J
    Folia Histochem Cytobiol; 2022; 60(3):203-214. PubMed ID: 36045602
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric Oncology.
    Balducci L; Falandry C; List A
    Curr Oncol Rep; 2022 Dec; 24(12):1695-1703. PubMed ID: 35986858
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ATPR regulates human mantle cell lymphoma cells differentiation via SOX11/CyclinD1/Rb/E2F1.
    Xu X; Zhang T; Zhang M; Li L; Deng G; Lu Z; Zhang Z; Du Y; Feng Y; Feng X; Peng X; Chen F
    Cell Signal; 2022 May; 93():110280. PubMed ID: 35151831
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms.
    Balasubramanian SK; Azmi AS; Maciejewski J
    Leukemia; 2022 Mar; 36(3):601-612. PubMed ID: 35091658
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma.
    Adamia S; Bhatt S; Wen K; Chyra Z; Fell GG; Tai YT; Pioso MS; Abiatari I; Letai A; Dorfman DM; Hideshima T; Anderson KC
    Leukemia; 2022 Apr; 36(4):1088-1101. PubMed ID: 35082402
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Clinical analysis of fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of 43 cases of chronic lymphoblastic leukemia].
    Wang TY; Yi SH; Wang Y; Lyu R; Wang Q; Deng SH; Sui WW; Fu MW; Huang WY; Liu W; An G; Zhao YZ; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2021 Jul; 42(7):543-548. PubMed ID: 34455740
    [No Abstract]    [Full Text] [Related]  

  • 16. Balanced and unbalanced translocations in a multicentric series of 2843 patients with chronic lymphocytic leukemia.
    Costa D; Granada I; Espinet B; Collado R; Ruiz-Xivillé N; Puiggros A; Uribe M; Arias A; Gómez C; Delgado J; Pereira A; Magnano L; Colomer D; López C; Beà S
    Genes Chromosomes Cancer; 2022 Jan; 61(1):37-43. PubMed ID: 34414624
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Proposal and clinical application of molecular genetic risk scoring system, "MRplus", for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre.
    Gupta SK; Bakhshi S; Kamal VK; Gupta R; Sharma P; Pushpam D; Sahoo RK; Sharma A
    Leuk Res; 2021 Dec; 111():106683. PubMed ID: 34371436
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pancracine, a Montanine-Type Amaryllidaceae Alkaloid, Inhibits Proliferation of A549 Lung Adenocarcinoma Cells and Induces Apoptotic Cell Death in MOLT-4 Leukemic Cells.
    Koutová D; Havelek R; Peterová E; Muthná D; Královec K; Breiterová K; Cahlíková L; Řezáčová M
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209868
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by activating the AKT/mTOR signaling pathway.
    Bao XY; Sun M; Peng TT; Han DM
    Cancer Biomark; 2021; 31(4):307-315. PubMed ID: 33896816
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. An unknown chromosomal aberration in a patient with chronic lymphocytic leukemia: Extra isochromosome 4q.
    Atli EI; Gurkan H; Demir AM
    J Cancer Res Ther; 2021; 17(1):282-287. PubMed ID: 33723172
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.